The only 'news' item I could find was in BIOWORLD Today, released on 28 August. It was in the 'other news to note' section:
"Antisense Therapeutics Ltd., of Melbourne, Australia, and Isis Pharmaceuticals Inc., of Carlsbad, Calif., began a Phase I trial of ATL1102 (ISIS 107248) for multiple sclerosis, the first antisense drug for that indication. ATL1102 inhibits VLA-4 (very late antigen- 4), a process the companies said results in positive effects in multiple animal models of inflammatory diseases, including multiple sclerosis. The double-blinded, placebo-controlled study will evaluate the pharmacokinetic and safety profile of ATL1102 in about 40 healthy volunteers in London. Isis licensed the compound to Antisense Therapeutics two years ago. (See BioWorld Today, Dec. 21, 2001.) "
Disclosure: I own ANPO
- Forums
- ASX - By Stock
- PER
- anyone aware of the news article?
anyone aware of the news article?, page-2
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
0.004(4.94%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.1¢ | 8.5¢ | 8.1¢ | $46.54K | 563.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 164616 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 100110 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 164616 | 0.081 |
3 | 143000 | 0.080 |
1 | 250000 | 0.079 |
3 | 71500 | 0.078 |
2 | 121300 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 100110 | 1 |
0.087 | 125000 | 1 |
0.089 | 102263 | 2 |
0.090 | 146175 | 1 |
0.091 | 108000 | 1 |
Last trade - 15.55pm 28/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online